$74.325
+0.14
(+0.2%)▲
Live
Insights on Merit Medical Systems Inc
Revenue is up for the last 2 quarters, 315.23M → 323.28M (in $), with an average increase of 2.5% per quarter
Netprofit is up for the last 3 quarters, 20.24M → 27.62M (in $), with an average increase of 14.1% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 25.5% return, outperforming this stock by 31.6%
In the last 3 years, Intuitive Surgical, Inc. has given 29.2% return, outperforming this stock by 13.3%
1.16%
Downside
Day's Volatility :1.57%
Upside
0.42%
15.81%
Downside
52 Weeks Volatility :26.91%
Upside
13.19%
Period | Merit Medical Systems Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -7.14% | 1.9% | 0.0% |
6 Months | 13.62% | 10.7% | 0.0% |
1 Year | -6.1% | 4.6% | -1.1% |
3 Years | 16.73% | 14.2% | -22.1% |
Market Capitalization | 4.3B |
Book Value | $20.78 |
Earnings Per Share (EPS) | 1.62 |
PE Ratio | 45.22 |
PEG Ratio | 1.91 |
Wall Street Target Price | 93.6 |
Profit Margin | 7.51% |
Operating Margin TTM | 10.21% |
Return On Assets TTM | 3.99% |
Return On Equity TTM | 8.05% |
Revenue TTM | 1.3B |
Revenue Per Share TTM | 21.83 |
Quarterly Revenue Growth YOY | 10.6% |
Gross Profit TTM | 519.1M |
EBITDA | 217.5M |
Diluted Eps TTM | 1.62 |
Quarterly Earnings Growth YOY | -0.17 |
EPS Estimate Current Year | 3.32 |
EPS Estimate Next Year | 3.64 |
EPS Estimate Current Quarter | 0.76 |
EPS Estimate Next Quarter | 0.71 |
What analysts predicted
Upside of 25.93%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 882.8M | ↑ 21.28% |
Net Income | 42.0M | ↑ 52.66% |
Net Profit Margin | 4.76% | ↑ 0.98% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 994.9M | ↑ 12.7% |
Net Income | 5.5M | ↓ 87.03% |
Net Profit Margin | 0.55% | ↓ 4.21% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 963.9M | ↓ 3.11% |
Net Income | -9.8M | ↓ 280.57% |
Net Profit Margin | -1.02% | ↓ 1.57% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 11.5% |
Net Income | 48.5M | ↓ 592.27% |
Net Profit Margin | 4.51% | ↑ 5.53% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 7.09% |
Net Income | 74.5M | ↑ 53.79% |
Net Profit Margin | 6.47% | ↑ 1.96% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 8.89% |
Net Income | 94.4M | ↑ 26.7% |
Net Profit Margin | 7.53% | ↑ 1.06% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 287.2M | ↓ 2.64% |
Net Income | 15.3M | ↓ 0.17% |
Net Profit Margin | 5.32% | ↑ 0.13% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 293.4M | ↑ 2.17% |
Net Income | 33.4M | ↑ 118.71% |
Net Profit Margin | 11.38% | ↑ 6.06% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 297.6M | ↑ 1.41% |
Net Income | 20.7M | ↓ 38.02% |
Net Profit Margin | 6.96% | ↓ 4.42% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 320.1M | ↑ 7.56% |
Net Income | 20.2M | ↓ 2.21% |
Net Profit Margin | 6.33% | ↓ 0.63% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 315.2M | ↓ 1.51% |
Net Income | 25.8M | ↑ 27.61% |
Net Profit Margin | 8.2% | ↑ 1.87% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 323.3M | ↑ 2.56% |
Net Income | 27.6M | ↑ 6.95% |
Net Profit Margin | 8.55% | ↑ 0.35% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↑ 45.71% |
Total Liabilities | 687.2M | ↑ 57.81% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↑ 8.48% |
Total Liabilities | 807.4M | ↑ 17.48% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↓ 5.29% |
Total Liabilities | 705.8M | ↓ 12.58% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↓ 0.97% |
Total Liabilities | 608.5M | ↓ 13.79% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↑ 0.95% |
Total Liabilities | 519.6M | ↓ 14.61% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 2.3B | ↑ 39.74% |
Total Liabilities | 1.1B | ↑ 116.19% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.07% |
Total Liabilities | 543.9M | ↓ 2.56% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.7B | ↑ 1.91% |
Total Liabilities | 519.6M | ↓ 4.47% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.7B | ↑ 1.21% |
Total Liabilities | 512.5M | ↓ 1.37% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↑ 9.11% |
Total Liabilities | 633.9M | ↑ 23.69% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↓ 1.58% |
Total Liabilities | 578.6M | ↓ 8.72% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.3B | ↑ 28.57% |
Total Liabilities | 1.1B | ↑ 94.12% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 86.5M | ↑ 37.95% |
Investing Cash Flow | -378.8M | ↑ 158.12% |
Financing Cash Flow | 328.3M | ↑ 240.13% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 77.8M | ↓ 10.08% |
Investing Cash Flow | -134.5M | ↓ 64.5% |
Financing Cash Flow | 33.5M | ↓ 89.79% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 165.3M | ↑ 112.39% |
Investing Cash Flow | -58.7M | ↓ 56.39% |
Financing Cash Flow | -95.7M | ↓ 385.41% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 147.2M | ↓ 10.91% |
Investing Cash Flow | -37.2M | ↓ 36.64% |
Financing Cash Flow | -98.4M | ↑ 2.85% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 114.3M | ↓ 22.37% |
Investing Cash Flow | -57.4M | ↑ 54.45% |
Financing Cash Flow | -60.3M | ↓ 38.78% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 35.5M | ↓ 8.5% |
Investing Cash Flow | -16.8M | ↑ 24.85% |
Financing Cash Flow | -27.1M | ↑ 104.99% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 28.0M | ↓ 21.08% |
Investing Cash Flow | -17.3M | ↑ 3.34% |
Financing Cash Flow | -5.7M | ↓ 78.76% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 14.5M | ↓ 48.07% |
Investing Cash Flow | -14.9M | ↓ 14.27% |
Financing Cash Flow | -497.0K | ↓ 91.36% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 17.3M | ↑ 18.84% |
Investing Cash Flow | -142.9M | ↑ 861.87% |
Financing Cash Flow | 141.5M | ↓ 28572.03% |
Sell
Neutral
Buy
Merit Medical Systems Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Merit Medical Systems Inc | 1.91% | 13.62% | -6.1% | 16.73% | 31.29% |
Intuitive Surgical, Inc. | -3.73% | 35.94% | 25.5% | 30.64% | 122.62% |
Resmed Inc. | -4.7% | 29.49% | -19.73% | -12.65% | 81.09% |
Becton, Dickinson And Company | -3.02% | -9.59% | -10.56% | -8.97% | 0.8% |
West Pharmaceutical Services Inc | 0.47% | 5.54% | 4.9% | 21.03% | 238.69% |
Alcon Ag | -2.66% | 10.52% | 10.19% | 6.08% | 42.56% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Merit Medical Systems Inc | 45.22 | 45.22 | 1.91 | 3.32 | 0.08 | 0.04 | NA | 20.78 |
Intuitive Surgical, Inc. | 66.71 | 66.71 | 7.13 | 6.27 | 0.16 | 0.08 | NA | 39.37 |
Resmed Inc. | 29.86 | 29.86 | 1.75 | 7.4 | 0.22 | 0.11 | 0.01 | 30.47 |
Becton, Dickinson And Company | 53.77 | 53.77 | 1.34 | 12.95 | 0.05 | 0.03 | 0.02 | 87.68 |
West Pharmaceutical Services Inc | 47.63 | 47.63 | 6.72 | 7.62 | 0.21 | 0.12 | 0.0 | 39.2 |
Alcon Ag | 41.13 | 41.13 | 4.59 | 3.06 | 0.05 | 0.02 | 0.0 | 41.81 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Merit Medical Systems Inc | Buy | $4.3B | 31.29% | 45.22 | 7.51% |
Intuitive Surgical, Inc. | Buy | $130.9B | 122.62% | 66.71 | 27.16% |
Resmed Inc. | Buy | $26.5B | 81.09% | 29.86 | 19.77% |
Becton, Dickinson And Company | Buy | $67.6B | 0.8% | 53.77 | 6.44% |
West Pharmaceutical Services Inc | Buy | $27.5B | 238.69% | 47.63 | 20.12% |
Alcon Ag | Buy | $39.8B | 42.56% | 41.13 | 10.3% |
BlackRock Inc
Vanguard Group Inc
William Blair Investment Management, LLC
State Street Corporation
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
Conestoga Capital Advisors, LLC
merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c
Organization | Merit Medical Systems Inc |
Employees | 6950 |
CEO | Mr. Fred P. Lampropoulos |
Industry | Health Technology |
Marqeta, Inc.
$74.33
+0.2%
Endeavor Group Holdings, Inc.
$74.33
+0.2%
Global X Nasdaq 100 Covered Call Etf
$74.33
+0.2%
Grupo Aeroportuario Del Sureste, Sabdecv
$74.33
+0.2%
Middleby Corp.
$74.33
+0.2%
Dnp Select Income Closed Fund
$74.33
+0.2%
Masonite International Corp
$74.33
+0.2%
Zillow Group, Inc. - Class C Shares
$74.33
+0.2%
Tenet Healthcare Corp.
$74.33
+0.2%